NCT01292226View on ClinicalTrials.gov

A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Kidney Transplantation

Interventions

DRUG

mycophenolate mofetil

1 g PO BID for 24 weeks

DRUG

antibody induction

According to manufacturer recommendation

DRUG

Cyclosporine

According to manufacturer recommendation

DRUG

corticosteroid

According to manufacturer recommendation

Trial Locations (7)

10126

Torino

25123

Brescia

37126

Verona

67100

Coppito

70124

Bari

80131

Napoli

00168

Roma

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01292226 - A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil). | Biotech Hunter | Biotech Hunter